beta blocker: be used in hypertension

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents agent
Weight: 0.65
, high blood pressure
Weight: 0.63
, heart disease
Weight: 0.63
, vasodilator
Weight: 0.62
Siblings atenolol
Weight: 0.53
, lung cancer
Weight: 0.33
, cystic fibrosis
Weight: 0.33
, agonist
Weight: 0.32
, blood clot
Weight: 0.32

Related properties

Property Similarity
be used in hypertension 1.00
be called hypertension 0.98
be used in angina 0.85
be contraindicated in diabetes mellitus 0.84
be contraindicated in diabetes 0.84
increase risk of diabetes 0.84
be contraindicated in patients with asthma 0.83
is risk factor for diabetes 0.82
be contraindicated in angina 0.82
be contraindicated in vasospastic angina 0.82

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.63
Rule weight: 0.66
Evidence weight: 0.96
Similarity weight: 0.98
Evidence: 0.89
Plausible(high blood pressure, be called hypertension) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension)
0.51
Rule weight: 0.66
Evidence weight: 0.94
Similarity weight: 0.82
Evidence: 0.83
Plausible(high blood pressure, is risk factor for diabetes) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension)

Plausibility inheritance from parent to child

0.05
Rule weight: 0.09
Evidence weight: 0.54
Similarity weight: 0.98
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.89
¬ Plausible(high blood pressure, be called hypertension)
0.04
Rule weight: 0.09
Evidence weight: 0.57
Similarity weight: 0.82
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.83
¬ Plausible(high blood pressure, is risk factor for diabetes)

Remarkability exclusitivity betweem a parent and a child

0.28
Rule weight: 0.58
Evidence weight: 0.50
Similarity weight: 0.98
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.57
¬ Remarkable(high blood pressure, be called hypertension)
0.19
Rule weight: 0.58
Evidence weight: 0.40
Similarity weight: 0.82
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.69
¬ Remarkable(high blood pressure, is risk factor for diabetes)

Remarkability from parent implausibility

0.41
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.98
Evidence: 0.89
Plausible(high blood pressure, be called hypertension) ⋁
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.49
¬ Plausible(beta blocker, be used in hypertension)
0.34
Rule weight: 0.42
Evidence weight: 0.99
Similarity weight: 0.82
Evidence: 0.83
Plausible(high blood pressure, is risk factor for diabetes) ⋁
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.49
¬ Plausible(beta blocker, be used in hypertension)

Salient implies Plausible

0.18
Rule weight: 0.28
Evidence weight: 0.64
Similarity weight: 1.00
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.70
¬ Salient(beta blocker, be used in hypertension)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.84
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.68
¬ Remarkable(beta blocker, be contraindicated in diabetes mellitus)
0.65
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.84
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.66
¬ Remarkable(beta blocker, be contraindicated in diabetes)
0.65
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.85
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.85
¬ Remarkable(beta blocker, be used in angina)
0.64
Rule weight: 0.85
Evidence weight: 0.90
Similarity weight: 0.84
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.73
¬ Remarkable(beta blocker, increase risk of diabetes)
0.64
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.82
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.64
¬ Remarkable(beta blocker, be contraindicated in vasospastic angina)
0.64
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.83
Evidence: 0.87
Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.67
¬ Remarkable(beta blocker, be contraindicated in patients with asthma)
0.59
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.85
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.65
¬ Salient(beta blocker, be used in angina)
0.57
Rule weight: 0.85
Evidence weight: 0.78
Similarity weight: 0.85
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.34
¬ Typical(beta blocker, be used in angina)
0.56
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.85
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.46
¬ Plausible(beta blocker, be used in angina)
0.55
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.84
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.78
¬ Salient(beta blocker, increase risk of diabetes)
0.54
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.82
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.79
¬ Salient(beta blocker, be contraindicated in vasospastic angina)
0.53
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.84
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.85
¬ Salient(beta blocker, be contraindicated in diabetes)
0.53
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.84
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in diabetes mellitus)
0.52
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.83
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.87
¬ Salient(beta blocker, be contraindicated in patients with asthma)
0.47
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.84
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.65
¬ Plausible(beta blocker, increase risk of diabetes)
0.45
Rule weight: 0.85
Evidence weight: 0.64
Similarity weight: 0.82
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.70
¬ Plausible(beta blocker, be contraindicated in vasospastic angina)
0.43
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.84
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.76
¬ Plausible(beta blocker, be contraindicated in diabetes)
0.43
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.84
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in diabetes mellitus)
0.42
Rule weight: 0.85
Evidence weight: 0.60
Similarity weight: 0.83
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.78
¬ Plausible(beta blocker, be contraindicated in patients with asthma)
0.42
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.84
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.65
¬ Typical(beta blocker, increase risk of diabetes)
0.37
Rule weight: 0.85
Evidence weight: 0.53
Similarity weight: 0.82
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.74
¬ Typical(beta blocker, be contraindicated in vasospastic angina)
0.35
Rule weight: 0.85
Evidence weight: 0.49
Similarity weight: 0.84
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.80
¬ Typical(beta blocker, be contraindicated in diabetes)
0.35
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.84
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.81
¬ Typical(beta blocker, be contraindicated in diabetes mellitus)
0.34
Rule weight: 0.85
Evidence weight: 0.48
Similarity weight: 0.83
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.82
¬ Typical(beta blocker, be contraindicated in patients with asthma)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.70
Salient(beta blocker, be used in hypertension) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.49
Plausible(beta blocker, be used in hypertension) ⋁
Evidence: 0.36
¬ Typical(beta blocker, be used in hypertension)

Typicality and Rermarkability incompatibility between a parent and a child

0.11
Rule weight: 0.51
Evidence weight: 0.25
Similarity weight: 0.82
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.86
¬ Typical(high blood pressure, is risk factor for diabetes)
0.09
Rule weight: 0.51
Evidence weight: 0.19
Similarity weight: 0.98
Evidence: 0.87
¬ Remarkable(beta blocker, be used in hypertension) ⋁
Evidence: 0.94
¬ Typical(high blood pressure, be called hypertension)

Typicality inheritance from parent to child

0.19
Rule weight: 0.48
Evidence weight: 0.40
Similarity weight: 0.98
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.94
¬ Typical(high blood pressure, be called hypertension)
0.18
Rule weight: 0.48
Evidence weight: 0.45
Similarity weight: 0.82
Evidence: 0.36
Typical(beta blocker, be used in hypertension) ⋁
Evidence: 0.86
¬ Typical(high blood pressure, is risk factor for diabetes)